Opendata, web and dolomites


Myelinic nanochannels in neurodegenerative diseases

Total Cost €


EC-Contrib. €






 MyeliNANO project word cloud

Explore the words cloud of the MyeliNANO project. It provides you a very rough idea of what is the project "MyeliNANO" about.

myelination    injury    unknown    therapeutic    glia    myelinic    glial    specialized    cns    myelinated    previously    lost    physiological    itself    possibility    proteins    atp    shift    pyruvate    couple    sclerosis    multiple    aging    sheath    involve    transported    made    mitochondria    intriguing    diverse    mechanism    neuroinflammation    cellular    function    disorders    light    differen    diseases    generate    reducing    risk    adaxonal    mice    aggregation    nanochannels    300    soma    metabolically    glycolytic    cytosolic    neurodegenerative    combined    genetic    hypothesize    ultrastructure    modifiers    brain    shed    myelin    axons    neuropsychiatric    metabolites    metabolism    oligodendrocyte    hypothesis    energy    lactate    propagation    oligodendroglial    found    misfolded    integrity    discovered    nanometer    underlying    independent    impulse    neurological    absence    axonassociated    axonal    physical    pave    myelinano    compartment    mechanisms    secondary    opens    survival    channels    neuroprotection    space    tools    paradigm    vulnerable    fast    functions    cells    oligodendrocytes    metabolic    perturbations   

Project "MyeliNANO" data sheet

The following table provides information about the project.


Organization address
city: Munich
postcode: 80539

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website
 Total cost 2˙500˙000 €
 EC max contribution 2˙500˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-ADG
 Funding Scheme ERC-ADG
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2021-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Myelin is made by highly specialized glial cells and enables fast axonal impulse propagation. We have discovered that oligodendrocytes in the CNS are, in addition to myelination, required for the integrity and survival of axons, independent of the presence or absence of myelin itself. More recently, we found the underlying mechanism and could show that glycolytic oligodendrocytes provide axons with pyruvate/lactate. These metabolites are transported through a system of myelinic nanochannels to the axonal compartment, in which mitochondria generate ATP. The finding was a paradigm-shift for the physiological function of axonassociated glia, and opens now the intriguing possibility that oligodendrocytes are important modifiers of neurological diseases in which myelinated axons are lost. This includes, in addition to multiple sclerosis, also classical neuropsychiatric disorders. We will generate novel genetic tools in mice that allow us to study the role myelin and secondary axonal loss in higher brain functions. We will test the challenging hypothesis that reducing oligodendroglial support of axonal metabolism is a risk for differen neurodegenerative disorders. These involve the previously neglected ultrastructure of CNS myelin with cytosolic (20-300 nanometer wide) channels within the myelin sheath. These 'nanochannels' couple the oligodendrocyte soma metabolically to the adaxonal space, but are vulnerable to aging and physical injury. We hypothesize that cellular mechanisms as diverse as neuroinflammation and the aggregation of misfolded proteins in myelinic nanochannels cause perturbations of the axonal energy metabolism. When combined, the findings of MyeliNANO will shed new light on previously unknown functions of CNS myelin and will pave the way for metabolic neuroprotection as a therapeutic approach to a range of neurodegenerative diseases.


year authors and title journal last update
List of publications.
2019 Michelle S Erwig, Julia Patzig, Anna M Steyer, Payam Dibaj, Mareike Heilmann, Ingo Heilmann, Ramona B Jung, Kathrin Kusch, Wiebke Möbius, Olaf Jahn, Klaus-Armin Nave, Hauke B Werner
Anillin facilitates septin assembly to prevent pathological outfoldings of central nervous system myelin
published pages: , ISSN: 2050-084X, DOI: 10.7554/elife.43888
eLife 8 2019-06-06
2019 Robert Fledrich, Dagmar Akkermann, Vlad Schütza, Tamer A. Abdelaal, Doris Hermes, Erik Schäffner, M. Clara Soto-Bernardini, Tilmann Götze, Axel Klink, Kathrin Kusch, Martin Krueger, Theresa Kungl, Clara Frydrychowicz, Wiebke Möbius, Wolfgang Brück, Wolf C. Mueller, Ingo Bechmann, Michael W. Sereda, Markus H. Schwab, Klaus-Armin Nave, Ruth M. Stassart
NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-09385-6
Nature Communications 10/1 2019-06-06
2019 Sina K. Stumpf, Stefan A. Berghoff, Andrea Trevisiol, Lena Spieth, Tim Düking, Lennart V. Schneider, Lennart Schlaphoff, Steffi Dreha-Kulaczewski, Annette Bley, Dinah Burfeind, Kathrin Kusch, Miso Mitkovski, Torben Ruhwedel, Philipp Guder, Heiko Röhse, Jonas Denecke, Jutta Gärtner, Wiebke Möbius, Klaus-Armin Nave, Gesine Saher
Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
published pages: , ISSN: 0001-6322, DOI: 10.1007/s00401-019-01985-2
Acta Neuropathologica 2019-06-06
2018 R. Fledrich, T. Abdelaal, L. Rasch, V. Bansal, V. Schütza, B. Brügger, C. Lüchtenborg, T. Prukop, J. Stenzel, R. U. Rahman, D. Hermes, D. Ewers, W. Möbius, T. Ruhwedel, I. Katona, J. Weis, D. Klein, R. Martini, W. Brück, W. C. Müller, S. Bonn, I. Bechmann, K. A. Nave, R. M. Stassart, M. W. Sereda
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-018-05420-0
Nature Communications 9/1 2019-04-18
2018 Hana Janova, Sahab Arinrad, Evan Balmuth, Marina Mitjans, Johannes Hertel, Mohamad Habes, Robert A. Bittner, Hong Pan, Sandra Goebbels, Martin Begemann, Ulrike C. Gerwig, Sönke Langner, Hauke B. Werner, Sarah Kittel-Schneider, Georg Homuth, Christos Davatzikos, Henry Völzke, Brian L. West, Andreas Reif, Hans Jörgen Grabe, Susann Boretius, Hannelore Ehrenreich, Klaus-Armin Nave
Microglia ablation alleviates myelin-associated catatonic signs in mice
published pages: 734-745, ISSN: 0021-9738, DOI: 10.1172/JCI97032
Journal of Clinical Investigation 128/2 2019-04-18
2018 Ruth M. Stassart, Wiebke Möbius, Klaus-Armin Nave, Julia M. Edgar
The Axon-Myelin Unit in Development and Degenerative Disease
published pages: , ISSN: 1662-453X, DOI: 10.3389/fnins.2018.00467
Frontiers in Neuroscience 12 2019-04-18
2018 Lucas Schirmer, Wiebke Möbius, Chao Zhao, Andrés Cruz-Herranz, Lucile Ben Haim, Christian Cordano, Lawrence R Shiow, Kevin W Kelley, Boguslawa Sadowski, Garrett Timmons, Anne-Katrin Pröbstel, Jackie N Wright, Jung Hyung Sin, Michael Devereux, Daniel E Morrison, Sandra M Chang, Khalida Sabeur, Ari J Green, Klaus-Armin Nave, Robin JM Franklin, David H Rowitch
Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity
published pages: , ISSN: 2050-084X, DOI: 10.7554/eLife.36428
eLife 7 2019-04-18
2018 Marie-Theres Weil, Saskia Heibeck, Mareike Töpperwien, Susanne tom Dieck, Torben Ruhwedel, Tim Salditt, María C. Rodicio, Jennifer R. Morgan, Klaus-Armin Nave, Wiebke Möbius, Hauke B. Werner
Axonal Ensheathment in the Nervous System of Lamprey: Implications for the Evolution of Myelinating Glia
published pages: 6586-6596, ISSN: 0270-6474, DOI: 10.1523/JNEUROSCI.1034-18.2018
The Journal of Neuroscience 38/29 2019-04-18
2017 Eva L. Feldman, Klaus-Armin Nave, Troels S. Jensen, David L.H. Bennett
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
published pages: 1296-1313, ISSN: 0896-6273, DOI: 10.1016/j.neuron.2017.02.005
Neuron 93/6 2019-04-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MYELINANO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MYELINANO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PSYDISC (2020)

Developing and Testing the Psychological Distance to Science Model

Read More  


Hyperpolarized Nuclear Magnetic Resonance Spectroscopy for Time-Resolved Monitoring of Interactions of Intrinsically Disordered Breast-Cancer Proteins

Read More  

EffectiveTG (2018)

Effective Methods in Tame Geometry and Applications in Arithmetic and Dynamics

Read More